{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:14:23Z","timestamp":1789496063278,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T00:00:00Z","timestamp":1282780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T00:00:00Z","timestamp":1282780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Diverse bone pathologies are observed in patients with psoriatic arthritis (PsA). Uncoupling of bone remodeling with disordered osteoclastogenesis has been implicated in the pathogenesis of PsA. The aim of this study was to examine the role of soluble mediators of bone remodeling within the circulation of patients with PsA.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Patients with PsA (<jats:italic>n<\/jats:italic> = 38), with psoriasis (<jats:italic>n<\/jats:italic> = 10), and healthy controls (<jats:italic>n<\/jats:italic> = 12) were studied. Serum was obtained for testing of Dikkopf-1 (Dkk-1), macrophage-colony stimulating factor (M-CSF), osteoprotegerin (OPG), and receptor activator of nuclear factor-\u03baB ligand (RANKL) with ELISA. Patients with PsA also had bone densitometry, plain radiographs of the hands and feet, and assessment of peripheral blood osteoclast precursors. Radiographs were scored for erosion, joint-space narrowing, osteolysis, and new bone formation.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Compared with those with psoriasis and healthy controls, patients with PsA had higher circulating concentrations of Dkk-1 and M-CSF. In patients with PsA, M-CSF and RANKL, but not Dkk-1, concentrations positively correlated with radiographic erosion, joint-space narrowing, and osteolysis scores. Mediators of bone remodeling did not correlate with the number of joints with new bone formation or with total hip-bone mineral density. Peripheral blood CD14<jats:sup>+<\/jats:sup>\/CD11b<jats:sup>+<\/jats:sup> cells, and the number of osteoclast-like cells and resorptive pits after culture with RANKL and M-CSF also correlated with radiographic damage scores. Circulating M-CSF concentrations correlated with the percentage of peripheral blood CD14<jats:sup>+<\/jats:sup>\/CD11b<jats:sup>+<\/jats:sup> cells.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Systemic expression of soluble factors that promote osteoclastogenesis is disordered in patients with PsA and may contribute to periarticular bone loss in this disease.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3123","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T18:15:09Z","timestamp":1282846509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion"],"prefix":"10.1186","volume":"12","author":[{"given":"Nicola","family":"Dalbeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bregina","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E","family":"Callon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M","family":"McQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,26]]},"reference":[{"key":"2953_CR1","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006, 54: 2665-2673. 10.1002\/art.21972.","journal-title":"Arthritis Rheum"},{"key":"2953_CR2","first-page":"2645","volume":"30","author":"WJ Taylor","year":"2003","unstructured":"Taylor WJ, Porter GG, Helliwell PS: Operational definitions and observer reliability of the plain radiographic features of psoriatic arthritis. J Rheumatol. 2003, 30: 2645-2658.","journal-title":"J Rheumatol"},{"key":"2953_CR3","first-page":"138","volume":"28","author":"B Frediani","year":"2001","unstructured":"Frediani B, Allegri A, Falsetti P, Storri L, Bisogno S, Baldi F, Filipponi P, Marcolongo R: Bone mineral density in patients with psoriatic arthritis. J Rheumatol. 2001, 28: 138-143.","journal-title":"J Rheumatol"},{"key":"2953_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/ard.2008.093617","volume":"68","author":"J Ly","year":"2009","unstructured":"Ly J, Pinto C, Doyle A, Dalbeth N, McQueen FM: Axial bone proliferation causing cervical myelopathy in the mutilans form of psoriatic arthritis despite peripheral bone erosion. Ann Rheum Dis. 2009, 68: 443-444. 10.1136\/ard.2008.093617.","journal-title":"Ann Rheum Dis"},{"key":"2953_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"SL Teitelbaum","year":"2007","unstructured":"Teitelbaum SL: Osteoclasts: what do they do and how do they do it?. Am J Pathol. 2007, 170: 427-435. 10.2353\/ajpath.2007.060834.","journal-title":"Am J Pathol"},{"key":"2953_CR6","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA. 1998, 95: 3597-3602. 10.1073\/pnas.95.7.3597.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2953_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93: 165-176. 10.1016\/S0092-8674(00)81569-X.","journal-title":"Cell"},{"key":"2953_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/35083081","volume":"3","author":"A Bafico","year":"2001","unstructured":"Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA: Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6\/Arrow. Nat Cell Biol. 2001, 3: 683-686. 10.1038\/35083081.","journal-title":"Nat Cell Biol"},{"key":"2953_CR9","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD: The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003, 349: 2483-2494. 10.1056\/NEJMoa030847.","journal-title":"N Engl J Med"},{"key":"2953_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1359\/jbmr.060311","volume":"21","author":"F Morvan","year":"2006","unstructured":"Morvan F, Boulukos K, Clement-Lacroix P, Roman S, Suc-Royer I, Vayssiere B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G: Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res. 2006, 21: 934-945. 10.1359\/jbmr.060311.","journal-title":"J Bone Miner Res"},{"key":"2953_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G: Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007, 13: 156-163. 10.1038\/nm1538.","journal-title":"Nat Med"},{"key":"2953_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/JCI200316069","volume":"111","author":"CT Ritchlin","year":"2003","unstructured":"Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM: Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003, 111: 821-831.","journal-title":"J Clin Invest"},{"key":"2953_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/path.2153","volume":"212","author":"S Colucci","year":"2007","unstructured":"Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Quarta L, Cirulli N, Mancini L, Corrado A, Grassi FR, Grano M: Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol. 2007, 212: 47-55. 10.1002\/path.2153.","journal-title":"J Pathol"},{"key":"2953_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/ard.2007.076091","volume":"67","author":"AP Anandarajah","year":"2008","unstructured":"Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, Haas-Smith SA, Ritchlin CT: The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis. Ann Rheum Dis. 2008, 67: 296-301. 10.1136\/ard.2007.076091.","journal-title":"Ann Rheum Dis"},{"key":"2953_CR15","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/ar2915","volume":"12","author":"YG Chiu","year":"2010","unstructured":"Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT: CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther. 2010, 12: R14-10.1186\/ar2915.","journal-title":"Arthritis Res Ther"},{"key":"2953_CR16","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1172\/JCI26132","volume":"115","author":"H Kitaura","year":"2005","unstructured":"Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, Teitelbaum SL: M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest. 2005, 115: 3418-3427. 10.1172\/JCI26132.","journal-title":"J Clin Invest"},{"key":"2953_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402: 304-309. 10.1038\/46303.","journal-title":"Nature"},{"key":"2953_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/art.10097","volume":"46","author":"K Redlich","year":"2002","unstructured":"Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, Turk B, Pietschmann P, Woloszczuk W, Haralambous S, Kollias G, Steiner G, Smolen JS, Schett G: Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum. 2002, 46: 785-792. 10.1002\/art.10097.","journal-title":"Arthritis Rheum"},{"key":"2953_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R: Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 2008, 58: 1299-1309. 10.1002\/art.23417.","journal-title":"Arthritis Rheum"},{"key":"2953_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U: Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978, 157: 238-244. 10.1159\/000250839.","journal-title":"Dermatologica"},{"key":"2953_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","volume":"43","author":"L Williamson","year":"2004","unstructured":"Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP: Extended report: nail disease in psoriatic arthritis: clinically important, potentially treatable and often overlooked. Rheumatology (Oxford). 2004, 43: 790-794. 10.1093\/rheumatology\/keh198.","journal-title":"Rheumatology (Oxford)"},{"key":"2953_CR22","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/art.22805","volume":"56","author":"D van der Heijde","year":"2007","unstructured":"van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, Zhou B, Dooley LT, de Vlam K, Geusens P, Birbara C, Halter D, Beutler A: Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum. 2007, 56: 2698-2707. 10.1002\/art.22805.","journal-title":"Arthritis Rheum"},{"key":"2953_CR23","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/art.23488","volume":"58","author":"N Dalbeth","year":"2008","unstructured":"Dalbeth N, Smith T, Nicolson B, Clark B, Callon K, Naot D, Haskard DO, McQueen FM, Reid IR, Cornish J: Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum. 2008, 58: 1854-1865. 10.1002\/art.23488.","journal-title":"Arthritis Rheum"},{"key":"2953_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","volume":"106","author":"HM Massey","year":"1999","unstructured":"Massey HM, Flanagan AM: Human osteoclasts derive from CD14-positive monocytes. Br J Haematol. 1999, 106: 167-170. 10.1046\/j.1365-2141.1999.01491.x.","journal-title":"Br J Haematol"},{"key":"2953_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2141.2000.02379.x","volume":"111","author":"V Shalhoub","year":"2000","unstructured":"Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Van G, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL: Characterization of osteoclast precursors in human blood. Br J Haematol. 2000, 111: 501-512. 10.1046\/j.1365-2141.2000.02379.x.","journal-title":"Br J Haematol"},{"key":"2953_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/rheumatology\/keg475","volume":"43","author":"L Williamson","year":"2004","unstructured":"Williamson L, Dockerty JL, Dalbeth N, McNally E, Ostlere S, Wordsworth BP: Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology (Oxford). 2004, 43: 85-88. 10.1093\/rheumatology\/keg475.","journal-title":"Rheumatology (Oxford)"},{"key":"2953_CR27","first-page":"393","volume":"19","author":"P Docherty","year":"1992","unstructured":"Docherty P, Mitchell MJ, MacMillan L, Mosher D, Barnes DC, Hanly JG: Magnetic resonance imaging in the detection of sacroiliitis. J Rheumatol. 1992, 19: 393-401.","journal-title":"J Rheumatol"},{"key":"2953_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/art.27231","volume":"62","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP: Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010, 62: 150-158. 10.1002\/art.27231.","journal-title":"Arthritis Rheum"},{"key":"2953_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/345442a0","volume":"345","author":"H Yoshida","year":"1990","unstructured":"Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 1990, 345: 442-444. 10.1038\/345442a0.","journal-title":"Nature"},{"key":"2953_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1172\/JCI200316924","volume":"111","author":"R Faccio","year":"2003","unstructured":"Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL: c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest. 2003, 111: 749-758.","journal-title":"J Clin Invest"},{"key":"2953_CR31","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3899\/jrheum.090346","volume":"36","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Landewe R, Tak PP, Ritchlin CJ, Ostergaard M, Mease PJ, El-Gabalawy H, Garnero P, Gladman DD, Fitzgerald O, Aletaha D, Bykerk VP, Bathon JM, Syversen SW, Boers M, Geusens P, Inman RD, Kraus VB, Kvien TK, Taylor WJ, Wells GA, van der Heijde D: Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria. J Rheumatol. 2009, 36: 1785-1791. 10.3899\/jrheum.090346.","journal-title":"J Rheumatol"},{"key":"2953_CR32","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3899\/jrheum090347","volume":"36","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Fitzgerald O, Wells GA, Gladman DD, Landewe R, Ostergaard M, Taylor WJ, Christensen R, Tak PP, Boers M, Syversen SW, Bathon JM, Ritchlin CJ, Mease PJ, Bykerk VP, Garnero P, Geusens P, El-Gabalawy H, Aletaha D, Inman RD, Kraus VB, Kvien TK, van der Heijde D: Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design. J Rheumatol. 2009, 36: 1792-1799. 10.3899\/jrheum090347.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3123\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:59:00Z","timestamp":1728385140000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,26]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,8]]}},"alternative-id":["2953"],"URL":"https:\/\/doi.org\/10.1186\/ar3123","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,26]]},"assertion":[{"value":"18 June 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R164"}}